Nikos Iatropoulos
Director/Board Member at Linnaeus Therapeutics, Inc.
Profile
Nikos Iatropoulos is currently a director at three different companies: Linnaeus Therapeutics, Inc., MixComm, Inc., and Leukovet.
Nikos Iatropoulos active positions
| Companies | Position | Start |
|---|---|---|
Linnaeus Therapeutics, Inc.
 Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Director/Board Member | - |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Director/Board Member | - |
MixComm, Inc.
 MixComm, Inc. SemiconductorsElectronic Technology MixComm, Inc. manufactures semiconductors for transformative wireless solutions. The firm is a fabless semiconductor company developing transformative solutions for emerging wireless applications and markets. The company was founded by Harish Krishnaswamy and Frank Lane in 2017 and is headquartered in Chatham, NJ. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
MixComm, Inc.
MixComm, Inc. SemiconductorsElectronic Technology MixComm, Inc. manufactures semiconductors for transformative wireless solutions. The firm is a fabless semiconductor company developing transformative solutions for emerging wireless applications and markets. The company was founded by Harish Krishnaswamy and Frank Lane in 2017 and is headquartered in Chatham, NJ. | Electronic Technology |
- Stock Market
- Insiders
- Nikos Iatropoulos
